Arcus biosciences reports quarterly loss per share of $0.38

Arcus biosciences announces fourth quarter and full year 2019 financial results and corporate updates.qtrly loss per share $0.38.anticipate that our cash, cash equivalents and investments will be sufficient to fund operations into 2021.q4 earnings per share view $-0.51 -- refinitiv ibes data.

RCUS Ratings Summary

RCUS Quant Ranking